[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Tandem Diabetes Care Reports Tomorrow With Infusion Set Shortage Still Unresolved

Tandem Diabetes Care (TNDM) reports second-quarter 2026 earnings after the close on August 6, 2026, with investors focused on whether the medical device maker can sustain its recent momentum of earnings beats and narrowing losses. The central question: can TNDM continue its trajectory toward profitability while navigating a competitive diabetes technology market, or will execution challenges derail the progress that has driven shares higher in recent months?

Tandem Diabetes Care develops and manufactures insulin delivery systems for people with diabetes, primarily its t:slim X2 insulin pump with Control-IQ technology. The company competes in the automated insulin delivery market and generates revenue through pump...

Fundamentals

See More
  • Market Capitalization, $K 1,342,483
  • Shares Outstanding, K 68,529
  • Annual Sales, $ 1,015 M
  • Annual Income, $ -204,710 K
  • EBIT $ -84 M
  • EBITDA $ -68 M
  • 60-Month Beta 1.54
  • Price/Sales 1.36
  • Price/Cash Flow N/A
  • Price/Book 10.45

Options Overview Details

View History
  • Implied Volatility 96.25% (-0.13%)
  • Historical Volatility 52.72%
  • IV Percentile 84%
  • IV Rank 57.73%
  • IV High 125.46% on 09/11/25
  • IV Low 56.36% on 11/11/25
  • Expected Move (DTE 15) 3.26 (17.45%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 962
  • Volume Avg (30-Day) 1,124
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 19,901
  • Open Int (30-Day) 18,387
  • Expected Range 15.40 to 21.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.34
  • Number of Estimates 6
  • High Estimate $-0.29
  • Low Estimate $-0.41
  • Prior Year $-0.48
  • Growth Rate Est. (year over year) +29.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.57 +28.68%
on 07/14/26
20.81 -9.88%
on 08/04/26
+3.33 (+21.63%)
since 07/06/26
3-Month
12.26 +52.98%
on 05/15/26
20.81 -9.88%
on 08/04/26
+0.72 (+4.02%)
since 05/06/26
52-Week
9.98 +87.93%
on 08/07/25
29.65 -36.75%
on 02/24/26
+4.36 (+30.33%)
since 08/06/25

Most Recent Stories

More News
Tandem Diabetes Care Reports Tomorrow With Infusion Set Shortage Still Unresolved

Barchart Research What to Expect from TNDM Earnings TNDM Generated August 5, 2026 Current Price $19.59 EPS Estimate $$-0.34 Consensus Rating Moderate Buy Average Move 20.70% Tandem Diabetes Care Reports...

TNDM : 18.80 (-4.03%)
Tandem Diabetes Earnings: What To Look For From TNDM

Tandem Diabetes Earnings: What To Look For From TNDM

TNDM : 18.80 (-4.03%)
Tandem Diabetes Care Announces Upcoming Conference Presentation

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuity’s 46 th...

TNDM : 18.80 (-4.03%)
3 Stocks Under $50 We Steer Clear Of

3 Stocks Under $50 We Steer Clear Of

WMG : 26.47 (+1.81%)
TNDM : 18.80 (-4.03%)
DXC : 11.02 (-0.90%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

TNDM : 18.80 (-4.03%)
ILMN : 193.52 (-3.18%)
HAE : 84.80 (+1.44%)
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:NVO),(NASDAQ:SNY),(NASDAQ:DXCM),(NASDAQ:TNDM) EQNX::TICKER_END

AVAI : 0.1221 (+1.67%)
TNDM : 18.80 (-4.03%)
NVO : 45.89 (+3.05%)
DXCM : 82.96 (+0.36%)
SNY : 42.87 (+0.21%)
1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges

1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges

TNDM : 18.80 (-4.03%)
WBD : 26.39 (+1.62%)
NET : 283.51 (-3.23%)
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

TNDM : 18.80 (-4.03%)
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down

1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down

JKHY : 156.90 (+1.65%)
SSTK : 5.90 (-5.45%)
TNDM : 18.80 (-4.03%)
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets

Compatibility now available in five countries, with additional markets expected throughout 2026.

TNDM : 18.80 (-4.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin...

See More

Key Turning Points

3rd Resistance Point 20.83
2nd Resistance Point 20.34
1st Resistance Point 19.97
Last Price 18.80
1st Support Level 19.11
2nd Support Level 18.62
3rd Support Level 18.25

See More

52-Week High 29.65
Fibonacci 61.8% 22.14
Fibonacci 50% 19.81
Last Price 18.80
Fibonacci 38.2% 17.49
52-Week Low 9.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.